Sirolimus Drug Eluting Coronary Stent System - India CDSCO Medical Device Registration

Sirolimus Drug Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000088_66f3cd7aab467388bc6f32798714cf55_726a9c04dc61cd2b12491646992a6e30. This device is marketed under the brand name NOVA MATRIX®. The license holder is Invent Biomed Private Limited, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.